Drug maker Allchem Lifescience has filed preliminary papers with markets regulator Sebi seeking its approval to raise funds ...

In August 2024, Madhabi Puri Buch, then-chairperson of India’s market regulator Securities and Exchange Board of India (Sebi) ...

Markets regulator Sebi has widened the ambit of the scope of Unpublished Price Sensitive Information (UPSI) by including any ...

One of the key factors was its decision to change the expiry for the Sensex F&O contract from Thursdays to Fridays. Following ...

Market regulator's gross position limits for derivatives may lead to job losses, impact levies, and discourage hedging.

The so-called 'product suitability framework' has not come up for discussions in recent meetings at Sebi, and there has been ...

The Securities and Exchange Board of India (SEBI) is considering tweaking its employee appraisal system by severing the link ...

Sebi has mandated completing rights issues within 23 working days from board approval, effective April 7, 2025. The move aims ...

The legal framework surrounding fair comment, influence-peddling, defamation and fraud in social media interactions is still ...

In a circular on Tuesday, Sebi came out with the revised timelines for completion of the various activities involved in ...

LG Electronics India, a subsidiary of LG, has received approval from Sebi for a Rs 15,000 crore initial public offering. This ...

SEBI may require retail F&O traders to pass a suitability test, ensuring they understand risks. Discover more on this ...